November 23, 2016 - By Louis Casey · 0 Comments
The stock of Allergan Plc (NYSE:AGN) registered a decrease of 1.63% in short interest. AGN’s total short interest was 10.36 million shares in November as published by FINRA. Its down 1.63% from 10.54M shares, reported previously. With 3.41M shares average volume, it will take short sellers 3 days to cover their AGN’s short positions. The short interest to Allergan Plc’s float is 2.83%. About 2.82M shares traded hands. Allergan plc Ordinary Shares (NYSE:AGN) has declined 16.99% since April 21, 2016 and is downtrending. It has underperformed by 22.32% the S&P500.
Insitutional Activity: The institutional sentiment increased to 4 in 2016 Q2. Its up 3.54, from 0.46 in 2016Q1. The ratio increased, as 11 funds sold all Allergan plc Ordinary Shares shares owned while 2 reduced positions. 3 funds bought stakes while 3 increased positions. They now own 58,328 shares or 8.83% less from 63,978 shares in 2016Q1.
Grassi Investment Management has 5,125 shares for 0.22% of their US portfolio. The California-based Dowling & Yahnke Ltd Limited Liability Company has invested 0.06% in Allergan plc Ordinary Shares (NYSE:AGN). Mengis Management last reported 1.27% of its portfolio in the stock. Connors Investor owns 1,000 shares or 0.04% of their US portfolio. Armstrong Henry H Inc accumulated 0.17% or 3,690 shares. Frontier Investment last reported 0.94% of its portfolio in the stock. Bartlett Ltd has 0.01% invested in the company for 494 shares. Chartist Ca, a California-based fund reported 1,844 shares. Marshwinds Advisory holds 0.1% or 927 shares in its portfolio. American Research & Management Comm has 0% invested in the company for 33 shares. The Alabama-based Mitchell Mcleod Pugh & Williams Inc has invested 0.83% in Allergan plc Ordinary Shares (NYSE:AGN). Moreover, Gemmer Asset Limited Com has 0.02% invested in Allergan plc Ordinary Shares (NYSE:AGN) for 127 shares.
Out of 18 analysts covering Allergan Inc. (NYSE:AGN), 14 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 78% are positive. Allergan Inc. has been the topic of 46 analyst reports since July 29, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Mizuho on Tuesday, February 23. The firm has “Neutral” rating given on Monday, April 18 by Guggenheim. Mizuho maintained it with “Buy” rating and $293.0 target price in Tuesday, November 1 report. On Thursday, April 7 the stock rating was reinitiated by JP Morgan with “Overweight”. The company was maintained on Friday, October 30 by S&P Research. The firm has “Neutral” rating given on Wednesday, April 6 by Mizuho. The rating was upgraded by TheStreet to “Buy” on Wednesday, July 29. Canaccord Genuity maintained the stock with “Buy” rating in Sunday, August 9 report. Mizuho maintained the shares of AGN in a report on Friday, May 13 with “Neutral” rating. As per Tuesday, July 28, the company rating was maintained by Leerink Swann.
Allergan plc, incorporated on May 16, 2013, is a specialty pharmaceutical company. The Firm is engaged in the development, manufacturing, marketing and distribution of pharmaceutical products, medical aesthetics, biosimilar and over-the-counter (OTC) pharmaceutical products. The Company’s divisions are US Brands, US Medical Aesthetics and International Brands. The US Brands segment includes sales and expenses relating to branded products within the United States, including certain Botox therapies. The US Medical Aesthetics segment includes sales and expenses relating to aesthetics and dermatology products within the United States, including certain Botox therapies. The International Brands segment includes sales and expenses relating to products sold outside of the United States.
More recent Allergan plc Ordinary Shares (NYSE:AGN) news were published by: Investorplace.com which released: “Why Valeant Pharmaceuticals Intl Inc (VRX), Allergan plc Ordinary Shares (AGN …” on November 02, 2016. Also Investorplace.com published the news titled: “Allergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars?” on September 20, 2016. Valuewalk.com‘s news article titled: “Allergan plc Ordinary Shares (AGN) Collapses On Treasury Ruling, Analysts React” with publication date: April 05, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Louis Casey